Few with CRC in sub-Saharan Africa receive guideline-concordant care

by

Fewer than one in 20 patients diagnosed with colorectal cancer (CRC) in Sub-Saharan Africa (SSA) receive guideline-concordant treatment, according to a study published in the September issue of the Journal of the National Comprehensive Cancer Network.

Leave A Comment

Your email address will not be published. Required fields are marked *